Chronic kidney disease trials in Greece

In Greece 13 Also abroad 798

13 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Where
Alexandroupoli, Athens, Heraklion, Ioannina, Patras, Thessaloniki
Age
18 years and over
People
5,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00
Phase 3Taking people
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Where
Athens, Ioannina, Maroussi, Paleo Faliro, Thessaloniki
Age
50 years and over
People
7,140 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00
No phaseEnrolling by invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
Where
Athens, Heraklion, Thessaloniki
Age
0 Minutes to 2 weeks
People
8,000 worldwide
Run by
Indiana University
See details and how to joinNCT06823115
Phase 2Taking people
Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
Where
Athens
Age
12 years to 18 years
People
18 worldwide
Run by
Vifor Fresenius Medical Care Renal Pharma
See details and how to joinNCT06593392 · EU 2023-509909-74-00
No phaseNot yet taking people in Greece
Acupuncture for Symptom Burden and Quality of Life in Patients With End-Stage Kidney Disease
Where
Heraklion
Age
18 years and over
People
160
Run by
University General Hospital of Heraklion
See details and how to joinNCT07887607
No phaseTaking people
SPYRAL GEMINI Pilot Study
Where
Athens
Age
18 years to 80 years
People
175 worldwide
Run by
Medtronic Vascular
See details and how to joinNCT06907147
No phaseTaking people
Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
Where
Athens
Age
18 years and over
People
130 worldwide
Run by
Medtronic Vascular
See details and how to joinNCT07115953
Phase 3Taking people
The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Where
Alexandroupolis, Athens, Chaïdári, Heraklion, Ioannina, Patras, Thessaloniki
Age
18 years and over
People
2,000 worldwide
Run by
The George Institute
See details and how to joinNCT06058585 · EU 2024-520253-21-00
Phase 3Taking people
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Where
Athens, Heraklion, Ioannina, Thessaloniki
Age
1 year to 18 years
People
100 worldwide
Run by
Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00
Phase 3Taking people
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Where
Athens, Heraklion, Ioannina, Larissa, Marousi, Piraeus, Rio, Thessaloniki
Age
18 years to 99 years
People
2,800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Alexandroupoli, Arta, Athens, Crete, Haidari, Ioannina, Larissa, Marousi, Ptolemaida, Rio, Thessaloniki
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
Phase 3Taking people
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Where
Alexandroupoli, Athens, Chaïdári, Chios, Heraklion, Ioannina, Larissa, Maroussi, Patras, Thessaloniki
Age
18 years and over
People
7,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00
Phase 3Taking people
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Where
Athens, Thessaloniki
Age
2 years to 17 years
People
24 worldwide
Run by
Amgen
See details and how to joinNCT03969329 · EU 2023-506471-10-00